Loading
institutionsInstitution
Fondazione IRCCS Istituto Nazionale dei Tumori
The Istituto Nazionale dei Tumori is Italy's national cancer institute and a leader in sarcoma, thoracic oncology, and immunotherapy.
Overview
Fondazione IRCCS Istituto Nazionale dei Tumori in Milan is Italy's national cancer institute and ranks twenty-seventh in the Newsweek/Statista oncology list. It is a sarcoma reference centre, with Alessandro Gronchi, Silvia Stacchiotti and Filippo de Braud among its clinicians, and it leads in peritoneal surface malignancy through HIPEC and PIPAC intraperitoneal chemotherapy, alongside thoracic oncology, immunotherapy and early-phase trials. OnCo links it to sarcomas of soft tissue, bone and GIST, to Fondazione AIRC, and to fellow IRCCS institutes San Raffaele and Regina Elena. Whether intraperitoneal chemotherapy earns its place against systemic treatment in randomised trials is the open question its surgical programme faces. Its sarcoma programme is the reason most readers come.
Location
Milan, IT
Type
cancer center
Website
Newsweek 2026 oncology rank
#27
OnCo score
#54 · 49 points (33 Newsweek + 0 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Fondazione IRCCS Istituto Nazionale dei Tumori, including child institutions. 1,282 works · 18,091 citations · 76% open access · 19% clinical trials · 2% reviews.
Oncology works per year
2562022
2612023
2612024
3022025
2022026
Most works
- Filippo Pietrantonio137 works
- Chiara Cremolini117 works
- Sara Lonardi101 works
- Francesca Bergamo64 works
- Paolo Corradini62 works
- Filippo de Braud55 works
- Lisa Salvatore51 works
- Paolo A. Ascierto49 works
- Daniele Rossini49 works
- Rosalba Miceli48 works
Most cited
- Sarcoma
- Peritoneal surface malignancy
Alessandro Gronchi
Chair, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori
Sarcoma surgeryRetroperitoneal sarcomaNeoadjuvant chemotherapy
Sarcoma surgeon who led the ISG-STS 1001 trial of histology-tailored neoadjuvant chemotherapy.
Filippo de Braud
Director, Medical Oncology and Hematology, INT Milan; Professor, University of Milan
Medical oncologyEarly-phase trialsGastrointestinal cancers
Filippo de Braud heads medical oncology and the phase 1 programme at Italy's national cancer institute.
Gustavo Galmozzi
Representative of Fondazione IRCCS Istituto Nazionale dei Tumori to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Gustavo Galmozzi represents Fondazione IRCCS Istituto Nazionale dei Tumori in the Organisation of European Cancer Institutes, which lists the centre among its members in Italy.
Marco Guzzo
Head, Head and Neck Surgery, INT Milan
Head and neck surgerySalivary gland tumours
Marco Guzzo is a head and neck surgeon at INT Milan.
Silvia Stacchiotti
Medical Oncologist, Adult Mesenchymal Tumour and Rare Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Rare sarcomasHistology-driven therapyChordoma and desmoid tumours
Italian oncologist who leads histology-specific trials in ultra-rare sarcomas and the Connective Tissue Oncology Society.
Similar pages
- TrialISG-STS 1001
Shares Alessandro Gronchi, Italian Sarcoma Group, Sarcomas (soft tissue, bone, GIST).
- IdeaA same-week expert second opinion for every rare cancer diagnosis
Shares Marco Guzzo, Alessandro Gronchi, Sarcomas (soft tissue, bone, GIST).
- InstitutionEuropean Society of Surgical Oncology
Shares Alessandro Gronchi, HIPEC / PIPAC (intraperitoneal chemotherapy).
- InstitutionPoliclinico Universitario A. Gemelli
Shares Fondazione AIRC per la ricerca sul cancro, IRCCS Regina Elena National Cancer Institute.
- InstitutionIEO (European Institute of Oncology)
Shares Fondazione AIRC per la ricerca sul cancro, IRCCS Ospedale San Raffaele.
- CancerDesmoplastic small round cell tumour
Shares HIPEC / PIPAC (intraperitoneal chemotherapy), Sarcomas (soft tissue, bone, GIST).
- CancerUndifferentiated pleomorphic sarcoma (UPS)
Shares Italian Sarcoma Group, Sarcomas (soft tissue, bone, GIST).